With the increasing prevalence of poorly soluble drugs in the pharmaceutical pipeline, Matt Finkelhor, commercial manager, Global Novel Polymers at Lubrizol, explores how to realise therapeutic potential with the right excipients.
Lubrizol
How to realise therapeutic potential with the right excipients
With the increasing prevalence of poorly soluble drugs in the pharmaceutical pipeline, Matt Finkelhor, commercial manager, Global Novel Polymers at Lubrizol, explores how to realise therapeutic potential with the right excipients.
Published:
|
5 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.